DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 5Pharmathen SA
03 4Actavis Inc
04 8Ajanta Pharma Limited
05 4Alembic Pharmaceuticals Limited
06 4Amneal Pharmaceuticals
07 4CSPC Pharmaceutical Group
08 3Centocor
09 4Helsinn Advanced Synthesis
10 8Inventia Healthcare Limited
11 44Janssen-Cilag
12 30Johnson & Johnson Innovative Medicine
13 3Krka
14 4Lupin Ltd
15 3Mepha Pharma
16 3Pantson Pharma Pvt. Limited
17 2RELIANCE FORMULATION PVT. LTD
18 4RK Pharma
19 6Sandoz B2B
20 4Sun Pharmaceutical Industries Limited
21 3Teva Pharmaceutical Industries
22 4Unichem Laboratories Limited
23 4Zydus Pharmaceuticals
24 16Blank
01 8Depot injection fluid, suspension
02 20ER Tablet
03 10Extended Release Tablet
04 9Extended Release Tablets
05 4INJ
06 12INJECTION PROLONGED RELEASE SUSPENSION
07 9Inj Susp
08 3LP Tablet
09 5PROLONGED-RELEASE TABLET
10 1Paliperidone 100Mg 1 Unit Parenteral Use Rp
11 1Paliperidone 150Mg 1 Unit Parenteral Use Rp
12 1Paliperidone 3Mg 28 Combined Oral Use Rp
13 1Paliperidone 50Mg 1 Unit Parenteral Use Rp
14 1Paliperidone 6Mg 28 Combined Oral Use Rp
15 1Paliperidone 75Mg 1 Unit Parenteral Use Rp
16 1Paliperidone 9Mg 28 Combined Oral Use Rp
17 5Prolonged Release Tablet
18 9Ret Tabl
19 3TAB
20 3TABLET (EXTENDED-RELEASE)
21 4TABLET, EXTENDED RELEASE; ORAL
22 52TABLET, EXTENDED RELEASE;ORAL
23 14Blank
01 4Countries Registered In: US (Filed 2012)
02 9DISCN
03 4Generic
04 7Originator
05 43RX
06 12Registered in US
07 4US (Filed 2012)
08 94Blank
01 21INVEGA
02 9Invega
03 1Invega 3Mg
04 1Invega 6Mg
05 1Invega 9Mg
06 2Invega Hafyera
07 5Invega Sustenna
08 4Invega Trinza
09 1PALICALM ER 3
10 1PALICALM ER 6
11 3PALIPERIDON KRKA
12 47PALIPERIDONE
13 3PALIPERIDONE SANDOZ
14 3PALIPERIDONE TEVA
15 2Paliperidon-Mepha retard
16 6Paliperidone Janssen
17 3Paliperidone Sandoz
18 1Paliperidone-Mepha retard
19 8Trevicta
20 1XEPLION 100 mg/1,0 ml
21 1XEPLION 150 mg/1,50 ml
22 1XEPLION 50 mg/0,50 ml
23 1XEPLION 75 mg/0,75 ml
24 19Xeplion
25 32Blank
01 14Australia
02 3Canada
03 5Greece
04 25India
05 20Italy
06 8Norway
07 7South Africa
08 17Sweden
09 18Switzerland
10 56USA
11 4Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1.5MG
Packaging :
Approval Date : 2015-08-03
Application Number : 202645
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2015-08-03
Application Number : 202645
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2015-08-03
Application Number : 202645
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-26
Application Number : 21999
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 22043
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number : 22043
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 9MG
Packaging :
Approval Date :
Application Number : 22043
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number : 22043
Regulatory Info :
Registration Country : USA
